Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 251 - 278 av 278 resultater
Tid
Selskap
Tittel
Sektor
Kategori
01 Sep 2021
18:30 CEST
NICOX
Number of voting rights as of August 31, 2021
20103015 Pharmaceuticals
Corporate life
01 Sep 2021
18:30 CEST
NICOX
Nombre de droits de vote au 31 août 2021
20103015 Pharmaceuticals
Corporate life
02 Aug 2021
17:45 CEST
NICOX
Nombre total de droits de vote au 31 juillet 2021
20103015 Pharmaceuticals
Corporate life
02 Aug 2021
17:45 CEST
NICOX
Number of voting rights as of July 31, 2021
20103015 Pharmaceuticals
Corporate life
16 Jul 2021
07:30 CEST
NICOX
Nicox : Point d’activité et résumé financier du second trimestre 2021 – Point sur la stratégie de la Société
20103015 Pharmaceuticals
New
16 Jul 2021
07:30 CEST
NICOX
Nicox Provides Second Quarter 2021 Business and Financial Highlights and Strategic Update
20103015 Pharmaceuticals
New
13 Jul 2021
07:30 CEST
NICOX
Nicox : Nomination du Dr. Robert N. Weinreb et du Dr. Sanjay G. Asrani au Comité consultatif clinique sur le glaucome de la Société
20103015 Pharmaceuticals
Corporate life
13 Jul 2021
07:30 CEST
NICOX
Nicox Appoints Robert N. Weinreb, M.D. and Sanjay G. Asrani, M.D. to its Glaucoma Clinical Advisory Board
20103015 Pharmaceuticals
Corporate life
06 Jul 2021
07:30 CEST
NICOX
Nicox: Half-year liquidity contract statement with Kepler Cheuvreux
20103015 Pharmaceuticals
New
06 Jul 2021
07:30 CEST
NICOX
Nicox : Bilan semestriel du contrat de liquidité avec Kepler Cheuvreux
20103015 Pharmaceuticals
New
05 Jul 2021
07:30 CEST
NICOX
Nicox to Receive $2 Million from Ocumension Therapeutics as Advance Milestone Payment under ZERVIATE® Agreement
20103015 Pharmaceuticals
New
05 Jul 2021
07:30 CEST
NICOX
Nicox : Paiement d'étape anticipé de 2 millions de dollars d’Ocumension Therapeutics dans le cadre de l'accord sur ZERVIATE®
20103015 Pharmaceuticals
New
02 Jul 2021
07:30 CEST
NICOX
Nicox Announces Last Patient Completed NCX 4251 Mississippi Phase 2b Blepharitis Trial
20103015 Pharmaceuticals
New
02 Jul 2021
07:30 CEST
NICOX
Nicox : Dernière visite du dernier patient dans l’étude de phase 2b Mississippi sur le NCX 4251 dans la blépharite
20103015 Pharmaceuticals
New
01 Jul 2021
17:45 CEST
NICOX
Number of voting rights as of June 30, 2021
20103010 Biotechnology
Corporate life
01 Jul 2021
17:45 CEST
NICOX
Nombre de droits de vote au 30 juin 2021
20103010 Biotechnology
Corporate life
01 Jul 2021
07:30 CEST
NICOX
Nicox’s NCX 470 Demonstrates Significant Intraocular Pressure Lowering in Dolomites Phase 2 Glaucoma Trial
20103010 Biotechnology
New
01 Jul 2021
07:30 CEST
NICOX
Nicox : Réduction significative de la pression intraoculaire avec le NCX 470 démontrée dans l’étude de phase 2 Dolomites dans le glaucome
20103010 Biotechnology
New
25 Jun 2021
07:30 CEST
NICOX
Nicox : Approbation de VYZULTA® (solution ophtalmique de latanoprostène bunod), 0,024% dans les Emirats arabes unis par son partenaire Bausch + Lomb
20103010 Biotechnology
New
25 Jun 2021
07:30 CEST
NICOX
Nicox’s Licensee Bausch + Lomb Receives Approval for VYZULTA® (latanoprostene bunod ophthalmic solution), 0.024% in the United Arab Emirates
20103010 Biotechnology
New
23 Jun 2021
17:45 CEST
NICOX
Nicox : Présentation au World Glaucoma E-Congress 2021 des résultats de l’étude de phase 2 Dolomites sur le NCX 470 chez des patients atteints de glaucome
20103010 Biotechnology
-
23 Jun 2021
17:45 CEST
NICOX
Nicox’s NCX 470 Dolomites Phase 2 Results in Glaucoma Patients To Be Presented at the World Glaucoma E-Congress 2021
20103010 Biotechnology
-
01 Jun 2021
17:45 CEST
NICOX
Nombre de droits de vote au 31 mai 2021
20103010 Biotechnology
Corporate life
01 Jun 2021
17:45 CEST
NICOX
Number of voting rights as of May 31, 2021
20103010 Biotechnology
Corporate life
01 Jun 2021
07:30 CEST
NICOX
Nicox’s Completes Pre-Defined Enrollment of NCX 4251 Mississippi Phase 2b Blepharitis Trial
20103010 Biotechnology
New
01 Jun 2021
07:30 CEST
NICOX
Nicox : Achèvement du recrutement pré-défini des patients dans l’étude de phase 2b Mississippi pour le NCX 4251 dans la blépharite
20103010 Biotechnology
New
05 May 2021
07:30 CEST
NICOX
Nicox partners with Laboratorios Grin to bring ZERVIATE to Mexico
20103010 Biotechnology
New
05 May 2021
07:30 CEST
NICOX
Nicox : Partenariat avec Laboratorios Grin pour ZERVIATE au Mexique
20103010 Biotechnology
New
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
«
« First
‹
‹‹
4
5
6
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva